tirzepatide side effects diarrhea and Diarrhea: Managing GLP-1 Digestive The Link Between Tirzepatide and

The clinical trials showed average weight loss of 1 to 2% body weight by week 4 and 5 to 6% by week 12

Notably, discontinuation of semaglutide resulted in a rapid and sustained improvement in kidney function ( In summary, given the increasing number of case reports on GLP-1 ARs-induced renal injury ( 5 Conclusion Although semaglutide has been widely used due to its efficacy in weight reduction and glycemic control, this first systematic review of case series highlights that semaglutide-associated kidney damage is a major clinical concern

TripleHormone-Receptor Agonist GLP-3 (RT) for Obesity

Risk Factors for PA and B12 Deficiency pernicious-anaemia-society

Doyle adds context on how oral Wegovy compares with other oral GLP-1s: "In trials, oral Wegovy achieved similar (~15%) weight loss to injectable (~17%)

While the products are clinically supported and designed for long-term results, users may need to show patience before seeing visible improvements